U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241013) titled 'Tissue-Engineered Construct Based on Amniotic Membrane and Calcium Alginate for Cesarean Section Wound Healing' on Nov. 16.
Brief Summary: This clinical trial aims to evaluate the safety and efficacy of an experimental tissue-engineered construct (TEC) based on amniotic membrane and calcium alginate for promoting epithelialization and improving scar quality in patients after cesarean section. The study will assess both biological and clinical indicators of wound healing, including cytokine dynamics (IL-6, IL-10), ultrasound characteristics, and patient-reported outcomes.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Con...